Naproxen-based non-steroidal anti-inflammatory drug with low gastric toxicity
AssigneesAO “Tatkhimfarmpreparaty”, Kazan Federal University
InventorsYurij G. Shtyrlin, Roman S. Pavel'Ev, Al'fiya G. Iksanova, Nikita V. Shtyrlin, Mikhail V. Pugachev, Konstantin V. Balakin, Aleksandr M. Ajmaletdinov, Il'nur M. Ganiev, Al'bina G. Malan'Eva
Life of this patent
Estimating the term…
Abstract
A new derivative of naproxen, 3-((S)-2-(6-methoxynaphth-2-yl) propanoyloxy)-4,5-bis (((S)-2-(6-methoxynaphth-2-yl) propanoyloxy)-methyl)-2-methylpyridinium (S)-2-(6-methoxynaphth-2-yl) propanoate has a high anti-inflammatory, analgesic and antipyretic activity, as well as low acute toxicity and gastrotoxicity, it can be used in the pharmaceutical industry, medicine and veterinary.
Claims1
A non-steroidal anti-inflammatory drug based on naproxen formula (I):
- having anti-inflammatory, analgesic and antipyretic activity, as well as reduced acute toxicity and gastric toxicity.
Dependencies are inferred from the claim text.